selected publications
- Necrotizing and Nonnecrotizing Granulomatous Reactions in Patients With Cancer Treated With Immune Checkpoint Inhibitors: A Systematic Literature Review. The Journal of rheumatology. 2025 Academic Article GET IT
- Opposing regulation of TNF responses by IFN-γ and a PGE2-cAMP axis that is apparent in rheumatoid and immune checkpoint inhibitor-induced arthritis human IL-1β+ macrophages. eLife. 2025 Academic Article GET IT
-
Impact of steroid-sparing immunosuppressive agents on tumor outcome in the context of cancer immunotherapy with highlight on melanoma: a systematic literature review and meta-analysis.
Frontiers in immunology.
2024
Review
GET IT
Times cited: 3 - Incidence of checkpoint inhibitor-associated inflammatory arthritis, immunomodulation and mortality in cancer patients on immunotherapy: a retrospective cohort study. Rheumatology (Oxford, England). 2024 Academic Article GET IT
- Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy. Rheumatic diseases clinics of North America. 2024 Review GET IT
-
Clonally expanded CD38hi cytotoxic CD8 T cells define the T cell infiltrate in checkpoint inhibitor-associated arthritis.
Science immunology.
2023
Academic Article
GET IT
Times cited: 29 -
Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 'shared epitope' are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis.
RMD open.
2023
Academic Article
GET IT
Times cited: 3 - 2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis. Arthritis & rheumatology (Hoboken, N.J.). 2023 Academic Article GET IT
- 2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis. Arthritis care & research. 2023 Academic Article GET IT
-
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis.
Annals of the rheumatic diseases.
2023
Academic Article
GET IT
Times cited: 50 - A "Gold Standard" in the Management of Arthritis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2023 Academic Article GET IT
- Monitoring and Management of the Patient with Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis: Current Perspectives. Journal of inflammation research. 2022 Review GET IT
-
Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition.
Journal for immunotherapy of cancer.
2022
Academic Article
GET IT
Times cited: 48 - Activated osteoarthritis following immune checkpoint inhibitor treatment: an observational study. Journal for immunotherapy of cancer. 2021 Academic Article GET IT
- Higher Checkpoint Inhibitor Arthritis Disease Activity may be Associated With Cancer Progression: Results From an Observational Registry. ACR open rheumatology. 2020 Academic Article GET IT
-
Autoimmune complications of immunotherapy: pathophysiology and management.
BMJ (Clinical research ed.).
2020
Academic Article
GET IT
Times cited: 21 -
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature.
The oncologist.
2019
Review
GET IT
Times cited: 51 -
Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor.
Annals of the rheumatic diseases.
2018
Article
GET IT
Times cited: 7